PerioTrap Pharmaceuticals GmbH
PrivateLast Round
VC Round
Feb 6, 2025
Total Funding Raised
$3.54M
Company Overview
PerioTrap Pharmaceuticals GmbH operates in Healthcare & Life Sciences and is based in Halle (Saale). Its latest recorded funding round was a VC Round in February 2025.
PerioTrap Pharmaceuticals GmbH is a life sciences company that develops an innovative anti-infective drug for the curative treatment of periodontitis, an inflammatory gum disease caused by specific bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty
Business Model
B2B2C
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PerioTrap Pharmaceuticals GmbH Comparables
Compare PerioTrap Pharmaceuticals GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ProEncia Biotechnology | 82% | |
| Kaneka Corporation | 66% | |
| Bausch Health Companies | 64% |
For institutional investors. Book with your work email.
PerioTrap Pharmaceuticals GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Feb 6, 2025 | ||||
| Seed | Oct 21, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PerioTrap Pharmaceuticals GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Bmp Ventures | VC Round |
| Fraunhofer Venture | Seed, VC Round |
| i&i Prague | Seed, VC Round |
| Companisto | VC Round |
PerioTrap Pharmaceuticals GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PerioTrap Pharmaceuticals GmbH's valuation, stock price, and market status.
Is PerioTrap Pharmaceuticals GmbH a public or private company?
PerioTrap Pharmaceuticals GmbH is a private company.
What is the current stock price of PerioTrap Pharmaceuticals GmbH?
PerioTrap Pharmaceuticals GmbH is a private company, so its shares have no public market price. Caplight tracks PerioTrap Pharmaceuticals GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PerioTrap Pharmaceuticals GmbH worth (valuation)?
Valuation information for PerioTrap Pharmaceuticals GmbH is not publicly available.
Can I buy PerioTrap Pharmaceuticals GmbH stock?
PerioTrap Pharmaceuticals GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PerioTrap Pharmaceuticals GmbH's last funding round?
PerioTrap Pharmaceuticals GmbH's most recent funding round was VC Round on February 6, 2025.
Who are the main investors in PerioTrap Pharmaceuticals GmbH?
Key investors in PerioTrap Pharmaceuticals GmbH include Bmp Ventures, Fraunhofer Venture, i&i Prague, Companisto.
Will PerioTrap Pharmaceuticals GmbH IPO soon?
No public IPO plans have been announced for PerioTrap Pharmaceuticals GmbH.
How can I track PerioTrap Pharmaceuticals GmbH secondary market activity?
Caplight tracks bids, offers, and trades in PerioTrap Pharmaceuticals GmbH's shares on secondary markets.